Immunosuppressive Agents: all 5,940 studies that test it
Page 50 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00550784Phase 1
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)CompletedNCT00549289Phase 3
- Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisCompletedNCT00548834Phase 3
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)CompletedNCT00548301Phase 3
- Study Evaluating the Efficacy and Safety of EtanerceptCompletedNCT00546533Phase 4
- A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple MyelomaCompletedNCT00545519Phase 1
- Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen EncephalitisStatus unknownNCT00545493Phase 2/3
- Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid LeukemiaStatus unknownNCT00544999Phase 1
- Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)Status unknownNCT00544505Not applicable
- Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)CompletedNCT00544232Phase 3
- PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneCompletedNCT00544219Not applicable
- Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid ArthritisCompletedNCT00544154Phase 3
- Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft FunctionStatus unknownNCT00541814Phase 4
- Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast CancerStatus unknownNCT00538395Not applicable
- Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver TransplantationCompletedNCT00538265Phase 4
- Tacrolimus Ointment Pharmacokinetics in Infants With Atopic DermatitisCompletedNCT00535691Phase 2
- Distribution of Tacrolimus in Skin, Atopic DermatitisCompletedNCT00534508Phase 2
- Safety and Efficacy of Vitreous Delineating Agent During VitrectomyCompletedNCT00532415Phase 3
- This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.CompletedNCT00531440Phase 3
- This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of EverolimusCompletedNCT00531063Phase 3
- Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma PatientsCompletedNCT00527657Phase 1
- Deflazacort in DysferlinopathiesCompletedNCT00527228Phase 2/3
- Proleukin and Rapamune in Type 1 DiabetesCompletedNCT00525889Phase 1
- Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast CancerCompletedNCT00525759Phase 2
- Interaction Between Rimonabant and Cyclosporine and TacrolimusCompletedNCT00525681Phase 4
- Etanercept Treatment in the Early Course of Polymyalgia RheumaticaCompletedNCT00524381Phase 3
- Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult PatientsCompletedNCT00523952Phase 3
- Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal CancerCompletedNCT00522665Phase 1/2
- Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent GlioblastomaStatus unknownNCT00521482Phase 2
- UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaCompletedNCT00519688Phase 2
- Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric CancerCompletedNCT00519324Phase 2
- Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant PatientsCompletedNCT00519116Phase 4
- Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With SirolimusCompletedNCT00518375Phase 4
- Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft RecipientsCompletedNCT00518271Phase 2
- Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and CisplatinTerminatedNCT00516750Phase 2
- Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast CancerStatus unknownNCT00516425Phase 3
- Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaCompletedNCT00516412Phase 2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
- High-Dose Methotrexate in Treating Young Patients With Solid TumorsCompletedNCT00513981Phase 1
- A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft FailureCompletedNCT00510913Phase 4
- Primary Breast Cancer Occurring Concomitant With PregnancyCompletedNCT00510367Early Phase 1
- Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldCompletedNCT00510003Phase 4
- Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical SettingCompletedNCT00509990Phase 4
- Phase 1 Study With Sorafenib and SirolimusCompletedNCT00509613Phase 1
- Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
- Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic DiseaseCompletedNCT00507832Phase 2
- Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving SirolimusCompletedNCT00507793Phase 4
- Safe Renal Function In Long Term Heart Transplanted PatientsStatus unknownNCT00505102Phase 4
- Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant RecipientsCompletedNCT00504543Phase 2
- Myfortic Versus Azathioprine in Systemic Lupus ErythematosusTerminatedNCT00504244Phase 3
- Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and CytarabineStatus unknownNCT00503594Phase 2
- Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male SubjectsCompletedNCT00502879Phase 1
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)CompletedNCT00502073Phase 3
- Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes MellitusCompletedNCT00501709Phase 1/2
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- Phase I Study of Patupilone and RAD001CompletedNCT00496600Phase 1
- MMF vs. AZA for Kidney TransplantationCompletedNCT00494741Phase 4
- Fibrosis in Renal AllograftsStatus unknownNCT00493194Phase 4
- A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on TacrolimusCompletedNCT00492661Phase 4
- Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and SafetyCompletedNCT00491517Phase 2
- Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAMStatus unknownNCT00490789Phase 2
- H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell HistiocytosisWithdrawnNCT00488605Phase 3
- Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic SyndromeCompletedNCT00488436Phase 4
- A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid ArthritisCompletedNCT00484237Phase 3
- A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic DermatitisCompletedNCT00484003Phase 4
- 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)CompletedNCT00483067Phase 2
- Abatacept in ANCA Associated VasculitisTerminatedNCT00482066Phase 2
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney TransplantationCompletedNCT00481819Phase 3
- Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant SubjectsCompletedNCT00481481Phase 3
- Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus OintmentCompletedNCT00480896Phase 3
- Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus OintmentCompletedNCT00480610Phase 3
- A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00478634Phase 1
- Intravitreal Triamcinolone Acetonide for Diabetic Macular EdemaStatus unknownNCT00476918Phase 1
- Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
- Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic BreastTerminatedNCT00473005Phase 1
- Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant RecipientsCompletedNCT00470665Phase 3
- Study of Methotrexate in Lupus ErythematosusCompletedNCT00470522Phase 3
- Safety and Efficacy Study of Thalomid in Patients With Chronic PancreatitisTerminatedNCT00469703Phase 2
- Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidCompletedNCT00469131Phase 3
- B-Lymphocyte Immunotherapy in Islet TransplantationTerminatedNCT00468442Phase 2
- LEA29Y (Belatacept) Emory Edmonton ProtocolCompletedNCT00468403Phase 2
- Efficacy of Islet After Kidney TransplantationCompletedNCT00468117Phase 3
- Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00467194Phase 1
- Effects of Antithymocyte Globulin in Adults With Myelodysplastic SyndromeStatus unknownNCT00466843Phase 2
- Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19Active, not recruitingNCT00466531Phase 1/2
- Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer PatientsCompletedNCT00466466Phase 1
- Efficacy of RAD001 in Breast Cancer Patients With Bone MetastasesStatus unknownNCT00466102Phase 2
- Strategies to Improve Islet SurvivalCompletedNCT00464555Phase 2
- Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant PatientsCompletedNCT00464399Phase 3
- Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating KeratoplastyTerminatedNCT00463723Phase 2/3
- Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade GliomaCompletedNCT00463008Not applicable
- Maintenance Neoral Monotherapy Compared to Bitherapy in Renal TransplantationCompletedNCT00461825Phase 3
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver TransplantationCompletedNCT00459719Phase 3
- Study Evaluating Etanercept in Patients With Ankylosing SpondylitisCompletedNCT00458185Phase 4
- RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMCompletedNCT00457964Phase 1/2
- Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAMCompletedNCT00457808Phase 2
- Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) PatientsCompletedNCT00457119Phase 1
- Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With ChemotherapyCompletedNCT00456833Phase 1